Max Healthcare

{
  "main_header": {
    "sid": 1003412,
    "name": "Max Healthcare",
    "stock_name": "Max Healthcare",
    "full_name": "Max Healthcare Institute Ltd",
    "name_url": "stocks-analysis/max-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,037.95",
    "chg": 25.45,
    "chgp": "2.51%",
    "dir": 1,
    "prev_price": "1,012.50",
    "mcapval": "99,349.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 543220,
    "symbol": "MAXHEALTH",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE027H01010",
    "curr_date": "May 11",
    "curr_time": "",
    "bse_nse_vol": "31.54 lacs",
    "exc_status": "Active",
    "traded_date": "May 11, 2026",
    "traded_date_str": "2026 05 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/max-healthcare-1003412-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Max Healthcare Institute Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/max-healthcare-institute-ltd-is-rated-sell-3985506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MaxHealthcareIn_mojoScore_3985506.png",
        "date": "2026-05-11 10:10:02",
        "description": "Max Healthcare Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "P/E at 67.54 vs Industry's 62.30: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-navigating-nifty-50-membership-and-institutional-shifts-3985001",
        "imagepath": "",
        "date": "2026-05-11 09:21:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> stands at 67.54, exceeding the hospital sector’s average P/E of 62.30 by approximately 8.5%. This premium valuation suggests that investors are pricing in expectations of superior earnings growth or operational resilience relative to peers. However, the premium is not excessively stretched compared to some other large-cap healthcare stocks, indicating a tempered optimism. The market cap of ₹98,536 crores classifies it firmly as a large-cap entity within the hospital sector.</p>\n                <p>Such a valuation gap invites scrutiny — <a href=\"https://www..."
      },
      {
        "title": "P/E at 67.48 vs Industry's 61.82: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-navigating-nifty-50-membership-amid-mixed-market-signals-3981034",
        "imagepath": "",
        "date": "2026-05-08 09:21:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> at 67.48 stands at a 9.1% premium over the hospital sector’s average P/E of 61.82. This elevated valuation suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, the premium also raises questions about the sustainability of such a valuation given the stock’s recent underperformance. The market cap of ₹98,244.09 crores places it firmly in the large-cap category, where valuation multiples tend to be more scrutinised by institutional investors.</p>\n                <p>Inte..."
      },
      {
        "title": "P/E at 67.77 vs Industry's 61.54: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-navigating-nifty-50-membership-amid-institutional-shifts-3979167",
        "imagepath": "",
        "date": "2026-05-07 09:21:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> currently trades at a P/E of 67.77, which is approximately 10.1% higher than the hospital industry’s average P/E of 61.54. This premium valuation suggests that investors are pricing in expectations of superior earnings growth or operational resilience relative to peers. However, the premium also raises questions about whether the stock’s price adequately reflects underlying fundamentals, especially given the recent performance trends. The elevated P/E ratio may imply stretched valuations in a sector where earnings visibility can be volatile due to regulatory and operational ..."
      },
      {
        "title": "P/E at 66.91 vs Industry's 60.79: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3977250",
        "imagepath": "",
        "date": "2026-05-06 09:21:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\" target=\"_blank\">Max Healthcare Institute Ltd</a> stands at 66.91, which is approximately 10.1% higher than the hospital industry average of 60.79. This premium valuation suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, such a premium also implies heightened risk should earnings disappoint or sector headwinds intensify. The market cap of Rs 97,300 crore classifies it firmly as a large-cap stock within the hospital sector, where valuation multiples tend to reflect both growth prospects and defensi..."
      },
      {
        "title": "P/E at 67.47 vs Industry's 60.94: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-navigating-nifty-50-membership-amid-institutional-shifts-3975402",
        "imagepath": "",
        "date": "2026-05-05 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> stands at 67.47, which is approximately 10.7% higher than the hospital sector’s average P/E of 60.94. This premium suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, such a valuation also implies heightened risk if earnings fail to meet elevated expectations. The sector’s P/E itself reflects the healthcare industry's growth prospects, but <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare</a> is clearly trading..."
      },
      {
        "title": "P/E at 66.34 vs Industry's 59.34: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-faces-downgrade-amid-mixed-market-performance-and-institutional-shifts-3973327",
        "imagepath": "",
        "date": "2026-05-04 10:30:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The elevated P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> at 66.34 versus the industry’s 59.34 suggests investors are pricing in expectations of stronger earnings growth or superior business quality relative to peers. This premium, while not extreme, is significant within the hospital sector, which typically commands moderate valuations due to regulatory and operational risks. The valuation gap implies that the market perceives <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare</a> as having a differentiated position, though the recent performance data..."
      },
      {
        "title": "Max Healthcare Institute Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/max-healthcare-institute-ltd-is-rated-sell-3970118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MaxHealthcareIn_mojoScore_3970118.png",
        "date": "2026-04-30 10:10:03",
        "description": "Max Healthcare Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "P/E at 67.07 vs Industry's 59.71: What the Data Shows for Max Healthcare Institute Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/max-healthcare-institute-ltd-faces-downgrade-amidst-mixed-market-performance-3969672",
        "imagepath": "",
        "date": "2026-04-30 09:21:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium P/E in Context</strong></p>\n                <p>The elevated P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/max-healthcare-1003412-0\" class=\"stk\">Max Healthcare Institute Ltd</a> at 67.07 compared to the industry’s 59.71 suggests the market is pricing in expectations of superior earnings growth or operational resilience relative to peers. However, this premium is not without its challenges. The hospital sector, characterised by capital-intensive operations and regulatory pressures, typically commands moderate valuations. The premium here may reflect investor confidence in the company’s brand and network, but it also raises questions about sustainability given recent performance trends — <a href=\"https://www.marketsmojo.com/stocks-an..."
      }
    ],
    "total": 887,
    "sid": "1003412",
    "stock_news_url": "https://www.marketsmojo.com/news/max-healthcare-institute-1003412"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Max Healthcare Institute Ltd has declared <strong>15%</strong> dividend, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Max Healthcare Institute Ltd is Rated Sell

2026-05-11 10:10:02

Max Healthcare Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

P/E at 67.54 vs Industry's 62.30: What the Data Shows for Max Healthcare Institute Ltd

2026-05-11 09:21:14

Valuation Picture: Premium Above Industry Average

The current P/E of Max Healthcare Institute Ltd stands at 67.54, exceeding the hospital sector’s average P/E of 62.30 by approximately 8.5%. This premium valuation suggests that investors are pricing in expectations of superior earnings growth or operational resilience relative to peers. However, the premium is not excessively stretched compared to some other large-cap healthcare stocks, indicating a tempered optimism. The market cap of ₹98,536 crores classifies it firmly as a large-cap entity within the hospital sector.

Such a valuation gap invites scrutiny — Read full news article

P/E at 67.48 vs Industry's 61.82: What the Data Shows for Max Healthcare Institute Ltd

2026-05-08 09:21:33

Valuation Picture: Premium Above Industry Average

The current P/E of Max Healthcare Institute Ltd at 67.48 stands at a 9.1% premium over the hospital sector’s average P/E of 61.82. This elevated valuation suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, the premium also raises questions about the sustainability of such a valuation given the stock’s recent underperformance. The market cap of ₹98,244.09 crores places it firmly in the large-cap category, where valuation multiples tend to be more scrutinised by institutional investors.

Inte...

Read full news article

P/E at 67.77 vs Industry's 61.54: What the Data Shows for Max Healthcare Institute Ltd

2026-05-07 09:21:22

Valuation Picture: Premium Above Industry Average

Max Healthcare Institute Ltd currently trades at a P/E of 67.77, which is approximately 10.1% higher than the hospital industry’s average P/E of 61.54. This premium valuation suggests that investors are pricing in expectations of superior earnings growth or operational resilience relative to peers. However, the premium also raises questions about whether the stock’s price adequately reflects underlying fundamentals, especially given the recent performance trends. The elevated P/E ratio may imply stretched valuations in a sector where earnings visibility can be volatile due to regulatory and operational ...

Read full news article

P/E at 66.91 vs Industry's 60.79: What the Data Shows for Max Healthcare Institute Ltd

2026-05-06 09:21:22

Valuation Picture: Premium Above Industry Average

The current P/E of Max Healthcare Institute Ltd stands at 66.91, which is approximately 10.1% higher than the hospital industry average of 60.79. This premium valuation suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, such a premium also implies heightened risk should earnings disappoint or sector headwinds intensify. The market cap of Rs 97,300 crore classifies it firmly as a large-cap stock within the hospital sector, where valuation multiples tend to reflect both growth prospects and defensi...

Read full news article

P/E at 67.47 vs Industry's 60.94: What the Data Shows for Max Healthcare Institute Ltd

2026-05-05 09:21:04

Valuation Picture: Premium Above Industry Average

The current P/E of Max Healthcare Institute Ltd stands at 67.47, which is approximately 10.7% higher than the hospital sector’s average P/E of 60.94. This premium suggests that investors are pricing in expectations of stronger earnings growth or superior operational performance relative to peers. However, such a valuation also implies heightened risk if earnings fail to meet elevated expectations. The sector’s P/E itself reflects the healthcare industry's growth prospects, but Max Healthcare is clearly trading...

Read full news article

P/E at 66.34 vs Industry's 59.34: What the Data Shows for Max Healthcare Institute Ltd

2026-05-04 10:30:50

Valuation Picture: Premium Above Industry Average

The elevated P/E ratio of Max Healthcare Institute Ltd at 66.34 versus the industry’s 59.34 suggests investors are pricing in expectations of stronger earnings growth or superior business quality relative to peers. This premium, while not extreme, is significant within the hospital sector, which typically commands moderate valuations due to regulatory and operational risks. The valuation gap implies that the market perceives Max Healthcare as having a differentiated position, though the recent performance data...

Read full news article

Max Healthcare Institute Ltd is Rated Sell

2026-04-30 10:10:03

Max Healthcare Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

P/E at 67.07 vs Industry's 59.71: What the Data Shows for Max Healthcare Institute Ltd

2026-04-30 09:21:16

Valuation Picture: Premium P/E in Context

The elevated P/E ratio of Max Healthcare Institute Ltd at 67.07 compared to the industry’s 59.71 suggests the market is pricing in expectations of superior earnings growth or operational resilience relative to peers. However, this premium is not without its challenges. The hospital sector, characterised by capital-intensive operations and regulatory pressures, typically commands moderate valuations. The premium here may reflect investor confidence in the company’s brand and network, but it also raises questions about sustainability given recent performance trends — Read full news article

View All News